142 related articles for article (PubMed ID: 1695305)
1. Isradipine: overall clinical experience in hypertension in the United States.
Miller H
J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S60-4. PubMed ID: 1695305
[TBL] [Abstract][Full Text] [Related]
2. Isradipine: overall clinical experience in hypertension in the United States.
Miller H
Am J Hypertens; 1991 Feb; 4(2 Pt 2):135S-139S. PubMed ID: 1827004
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of the new calcium antagonist isradipine in essential hypertension.
Kirch W; Burger KJ; Weidinger G; Welzel D
J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S55-9. PubMed ID: 1695304
[TBL] [Abstract][Full Text] [Related]
4. Calcium antagonists as first-line antihypertensive agents: a placebo-controlled, comparative trial of isradipine and nifedipine.
Welzel D; Burger KJ; Weidinger G
J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S70-4. PubMed ID: 1695308
[TBL] [Abstract][Full Text] [Related]
5. Central hemodynamics and brachial artery compliance during therapy with isradipine, a new calcium antagonist.
Andersson OK; Persson B; Widgren BR; Wysocki M
J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S87-9. PubMed ID: 1695312
[TBL] [Abstract][Full Text] [Related]
6. The long-term effect of isradipine in pindolol-treated patients.
Dahlöf B; Andrén L; Eggertsen R; Jern S; Svensson A; Hansson L
J Hypertens Suppl; 1987 Dec; 5(5):S567-70. PubMed ID: 2965231
[TBL] [Abstract][Full Text] [Related]
7. Isotonic and isometric responses of blood pressure and heart rate in mild to moderate hypertension with isradipine and propranolol.
Cantor A; Cristal N
J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S76-8. PubMed ID: 1695309
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of isradipine in hypertension.
Shepherd AM; Carr AA; Davidov M; Hamilton J; Schnaper H; Velasquez M; Brockway B; Prisant LM; Hamilton B; Gonasun L
J Cardiovasc Pharmacol; 1989 Apr; 13(4):580-5. PubMed ID: 2470995
[TBL] [Abstract][Full Text] [Related]
9. [Antihypertensive effect and adverse effects of isradipine in patients with sever hypertension. Results of an open multicenter study].
Burger KJ; Dehner R
Arzneimittelforschung; 1996 Jun; 46(6):600-5. PubMed ID: 8767350
[TBL] [Abstract][Full Text] [Related]
10. Isradipine vs propranolol in hydrochlorothiazide-treated hypertensives. A multicenter evaluation.
Prisant LM; Carr AA; Nelson EB; Winer N; Velasquez MT; Gonasun LM
Arch Intern Med; 1989 Nov; 149(11):2453-7. PubMed ID: 2530945
[TBL] [Abstract][Full Text] [Related]
11. [Electrophysiologic effects of the calcium antagonist isradipine, a double-blind placebo controlled study].
Kühlkamp V; Mayer F; Mauser M; Haasis R; Seipel L
Z Kardiol; 1990 Jun; 79(6):436-40. PubMed ID: 2143045
[TBL] [Abstract][Full Text] [Related]
12. First clinical experience with isradipine in the treatment of hypertension in Portugal.
Rocha-Gonçalves F; Mariano-Pego G; Viegas J; Correia JM; Botelho MA
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S4-6. PubMed ID: 1720485
[TBL] [Abstract][Full Text] [Related]
13. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
[TBL] [Abstract][Full Text] [Related]
14. A randomized comparison of isradipine slow release given once daily with isradipine twice daily on 24 hour blood pressure in hypertensive patients.
Christensen HR; Kampmann JP; Simonsen K
J Hum Hypertens; 1991 Apr; 5(2):121-7. PubMed ID: 1830108
[TBL] [Abstract][Full Text] [Related]
15. Tolerability of isradipine in the treatment of mild-to-moderate hypertension in general practice: a large-scale surveillance study.
Hermans L; Bogaert M; Degaute JP; Rorive G; Six R; Bara L; Lanssiers P; De Keyser P; Westelinck KJ
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S38-45. PubMed ID: 1376833
[TBL] [Abstract][Full Text] [Related]
16. Platelet aggregation and metabolic control are not affected by calcium antagonist treatment in type II diabetes mellitus.
Klauser R; Speiser P; Gisinger C; Schernthaner G; Prager R
J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S93-6. PubMed ID: 1695314
[TBL] [Abstract][Full Text] [Related]
17. 24-hour ambulatory blood pressure monitoring in the treatment of mild hypertension with isradipine.
Cihák R; Widimský J; Janský P; Lefflerová K
Cor Vasa; 1990; 32(2 Suppl 1):54-60. PubMed ID: 2143460
[TBL] [Abstract][Full Text] [Related]
18. Treatment of hypertension with dihydropyridine calcium antagonists and aspirin.
Tison P; Ulicna L; Jakubovska Z; Oravcova J; Fetkovska N
Blood Press Suppl; 1994; 1():57-60. PubMed ID: 8205303
[TBL] [Abstract][Full Text] [Related]
19. [The treatment of chronic stable angina with isradipine. A cooperative Latin American study].
Román O; Alcocer L; Espinoza J; Arcos R; Gómez G; Mayorga E; Buzzi A; Tavella N; Romero C; Kuster F
Rev Esp Cardiol; 1991 Apr; 44(4):233-40. PubMed ID: 1829846
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of isradipine (Lomir) with special emphasis on haemodynamics and antihypertensive efficacy. A review.
Dahlöf B
Cor Vasa; 1990; 32(2 Suppl 1):23-34. PubMed ID: 2143458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
